Navigator Medicines Stock
Navigator Medicines develops bispecific and monoclonal antibody therapies aimed at treating challenging autoimmune diseases by targeting immune-modulating pathways, such as OX40L and TNFα. It is focused on advancing a pipeline of novel biologics intended to provide safer, more durable symptom relief where existing treatments fall short.
Sign up for SecondMarket® to view the market and buy or sell Navigator Medicines Stock
Buy + SellSee Navigator Medicines Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Navigator Medicines Stock Valuation + Share Prices
View real-time Tape D® data on Navigator Medicines stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Get Started
Navigator Medicines Management Team
-
Board Member
Andrew Levin
-
Board Member
Wouter Joustra
-
CEO, President
Tausif Butt
-
Chief Medical Officer
Dana McClintock
-
Chief of Staff
Mark McLaughlin
-
Chief Scientific Officer
Kristie Grebe
Learn More About Navigator Medicines Stock
Buy Navigator Medicines Stock
01Navigator Medicines stock does not trade on public stock exchanges. Navigator Medicines stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Navigator Medicines stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Navigator Medicines Stock
02Navigator Medicines Stock does not trade on public stock exchanges. In order to sell Navigator Medicines shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Navigator Medicines Stock Price
03Navigator Medicines does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Navigator Medicines share price and other valuable private market data.
Read more about secondary market private company stock prices:
Navigator Medicines Stock Ticker Symbol
04There is no ticker symbol for Navigator Medicines stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Navigator Medicines Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Navigator Medicines stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Navigator Medicines Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Navigator Medicines stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Navigator Medicines Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Navigator Medicines IPO
08Navigator Medicines is a private company and has not had an IPO. There is currently no Navigator Medicines IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Navigator Medicines IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket® to view the market and buy or sell Navigator Medicines Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.